Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2009-09-14
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Taiwan THL Co.LTd.
- Target Recruit Count
- 60
- Registration Number
- NCT00976365
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei city, Taiwan
News
No news found